Dydrogesterone was initially approved by the U.S. Food and Drug Administration (FDA) in. 

Dydrogesterone is utilized for various gynecological conditions due to its progesterone-like effects. It is commonly prescribed for treating menstrual disorders, including irregular cycles, dysfunctional uterine bleeding, and premenstrual syndrome. Additionally, it is used in hormone replacement therapy, especially in postmenopausal women, and in assisted reproductive technologies to support embryo implantation. It is also employed in cases of threatened miscarriage, where it aids in maintaining the pregnancy. 

Dydrogesterone is typically administered orally as tablets. Sometimes, it may also be administered vaginally, usually as vaginal tablets or suppositories. The recommended starting dosage and any necessary dose adjustments are determined based on the specific condition being treated and the patient's response to the medication. 

Dydrogesterone may lead to various side effects. Commonly reported side effects include headaches, nausea, bloating, breast discomfort, and mood changes. Although these effects are usually mild, serious side effects are rare and may involve allergic reactions, liver problems, and symptoms of blood clots, such as severe headache or chest pain. 

After taking Dydrogesterone, cardiovascular risks such as an increased risk of blood clots can occur. There is a higher susceptibility to thromboembolic disorders. There is a possible association with certain types of malignancies. There is potential for abnormal vaginal bleeding.

There should be close monitoring in patients with existing heart conditions after taking Dydrogesterone. Use with caution in those with a history of blood clotting issues. Consider risks in patients with a history of certain cancers. Evaluate any abnormal bleeding promptly.

Firstly, individuals with known allergies to this medication should avoid using  Dydrogesterone. People with liver issues must be cautious, as it could affect liver function. Those with a history of blood clotting problems or cardiovascular disorders should use this medication carefully. It is essential to be cautious if you have diabetes or a history of depression, as this medication might impact these conditions. Additionally, inform your healthcare provider about any other medications you are taking and if you are pregnant, breastfeeding, or have adrenal insufficiency. Smokers should know that smoking may increase certain risks associated with this medication. Regular monitoring and open communication with your healthcare provider are vital to ensure safe usage.

1. Mylan,Electronic medicines compendium (EMC), [Revised on 12th Apr 2022] [Accessed on 19th Oct 2023],https://www.medicines.org.uk/emc/product/5523/smpc#gref

The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.